We predict that overexpression of Tbx20 or cardiomyocyte-specific expression of Bmp2 signaling could be exploited as a novel therapeutic approach to confer protection against prolonged ER stress and shift the balance toward prosurvival to restore cardiac homeostasis during ER stress–induced cardiomyopathy. This evidence concerns the gene TBX20 and cardiomyopathy.